After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...

Cutaneous vasculitis (CV) is a term used for inflammation of the blood vessels in the skin that occurs in up to 70% of patients with lupus erythematosus (LE). The inflammation affects the smaller ...

Considering taking supplements to treat cutaneous lupus erythematosus cle? Below is a list of common natural remedies used to treat or reduce the symptoms of cutaneous lupus erythematosus cle.

In a small phase II trial of cutaneous lupus erythematosus (CLE), patients treated with the TYK2 inhibitor had as much as 50% improvement in disease status at week 16. Adverse events in both ...

Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...

Lupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and damaging organs. A new study co-led by the University of Zurich has now shown ...

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes to treatment. Cutaneous lupus erythematosus is a common manifestation ...

The foregoing results lead to the conclusion that patients with disseminated lupus erythematosus and some patients with rheumatoid arthritis present a delayed cutaneous hypersensitivity when ...

More information: Henry W. Chen et al, Incidence and Prevalence of Atherosclerotic Cardiovascular Disease in Cutaneous Lupus Erythematosus, JAMA Dermatology (2024). DOI: 10.1001/jamadermatol.2024.4991 ...